Narcan Creator Takes on Synthetic Opioid Overdoses with Experimental Nasal Spray

 Opiant Pharmaceuticals, which developed Narcan (nasal naloxone), is now assessing a sister product aimed at synthetic opioids. Earlier this month, Opiant announced positive pharmacokinetic data for OPNT003, an investigational nasal nalmefene formulation for opioid overdose.